Vanderbilt research contributed to first COVID-19 pill now u

The drug, known as molnupiravir, was first shown to be efficacious against coronaviruses, including the COVID-19 virus, SARS-CoV-2, by investigators at Vanderbilt University Medical Center.

Related Keywords

Timothy Sheahan , Mark Denison , Andrea Pruijssers , Edward Claiborne Stahlman , Emory Institute For Drug Development , Vanderbilt University Medical Center , University Of North Carolina At Chapel Hill , National Institutes Of Health , Drug Administration , Merck Co , North Carolina , Memory Institute , Drug Development , Miami Based Ridgeback Therapeutics , Edward Claiborne Stahlman Chair , Pediatric Physiology , Cell Metabolism , Ralph Baric , National Institutes , Health Care , Wellness ,